Charleston, SC -- (SBWIRE) -- 08/26/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: Fuelstream Inc (OTCMKTS:FLST), TNI BIOTECH INC (OTCMKTS:TNIB), Advanced Cell Technology, Inc. (OTCBB:ACTC), Applied DNA Sciences Inc (OTCBB:APDN)
Fuelstream Inc (OTCMKTS:FLST) remained a bull for the day as it reported the upward momentum of +58.33% and closed at $0.190 after gaining total volume of 1.21 million shares. Its introductory price for the day was $0.13. So far, the company’s stock is down -89.73% in the three months period. In the last 6 months of trade it reported a decline of -87.33%.
FuelStream, Inc. operates as a fuel transportation and logistics company in the United States and internationally. The company acts as an in-wing and on-location supplier and distributor of aviation fuel to corporate, commercial, military, and privately-owned aircraft.
What was the Moving Force behind FLST On Bullish Run? Read This Research Report
TNI BIOTECH INC (OTCMKTS:TNIB) reported the gain of +27.17% and closed at $ 2.20 with the total traded volume of 151,976 shares. The stock's opening price was $ 1.70. The company has a total market capitalization of $ 101.87 million.
The 52-week price range of the stock remained $0.72 - $10.20, while during last trade its minimum price was $1.60 and it gained its highest price of $2.20. Company's last 5 days shows an uptrend with an upsurge of +19.57%. TNI BioTech, Inc., a specialty pharmaceutical company, focuses on developing and commercializing therapeutic products for the treatment of cancer, HIV/AIDS, hospitalization related, and infectious diseases in the United States and internationally.
For How Long TNIB will Fight for Profitability? Read This Trend Analysis report
Advanced Cell Technology, Inc. (OTCBB:ACTC) ended its day with the declining stream with the plunge of -0.78% and closed at the price of $0.0635 after opening at $0.06. Stock traded during its last trading session with the total volume of 5.77 million shares, as compared to its average volume of 8.33 million shares.
During the previous session, the company’s minimum price was $0.06, while it touched its highest price for the day at $0.06. ACTC’s beta value stands at -2.13 points. Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine.
Why Should Investors Buy ACTC After the Recent Fall? Just Go Here and Find Out
Applied DNA Sciences Inc (OTCBB:APDN) reported the increase of +8.93%, to close at $0.139, with the overall traded volume of 1.72 million shares.
So far, in the past three months, the stock is down -36.82%. The 52-week range for the stock is $0.11 and $0.31 and during the previous trading session the stock touched its highest price at $0.14. Its introductory price for the day was $0.13. Applied DNA Sciences, Inc. provides botanical-DNA based security and authentication solutions in Europe and the United States. The company offers SigNature DNA markers for embedding into a range of products, including various inks, dyes, textile treatments, thermal ribbon, thread, varnishes, and adhesives.
Will APDN Continue To Move Higher? Find Out Here
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)